Hepatotoxicity and Drug/Chemical Interaction Toxicity of Nanoclay Particles in Mice

被引:14
|
作者
Isoda, Katsuhiro [1 ]
Nagata, Ryutaro [1 ]
Hasegawa, Tomoya [1 ]
Taira, Yuichiro [1 ]
Taira, Ikuko [1 ]
Shimizu, Yoshimi [1 ]
Isama, Kazuo [1 ]
Nishimura, Tetsuji [1 ]
Ishida, Isao [1 ]
机构
[1] Teikyo Heisei Univ, Fac Pharmaceut Sci, 4-21-2 Nakano Ku, Tokyo 1648530, Japan
来源
关键词
Nanoclay particles; Liver injury; Carbon tetrachloride; Paraquat; Cisplatin; CARBON-TETRACHLORIDE; NANOPARTICLES; CISPLATIN; DIAGNOSIS; EXPOSURE; INJURY; GENE; DRUG;
D O I
10.1186/s11671-017-1956-5
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Nanomaterials are relatively new and unconventional materials with many useful properties, but their effects on biological systems are poorly understood. Nanoclay is a general term for layered mineral silicate nanoparticles that are ideally suited for use in clay-based nanocomposites. The potential biological hazards of nanoclays have not been addressed, however. Therefore, we investigated the in vivo effects and drug interactions of nanoclays. In mice, administration of nanoclay particles via the tail vein led to acute liver injury. Co-administration of nanoclay and carbon tetrachloride, paraquat, or cisplatin resulted in both liver and kidney injury. Our findings thus indicate that nanoclay particles are potentially hepato-and nephrotoxic.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] CARB 21-Electrostatic interaction between polysaccharides and nanoclay particles used for nanoencapsulation
    Liang, Songmiao
    Liu, LinShu
    Huang, Qingrong
    Yam, Kit
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [23] Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz
    German, Polina
    Greenhouse, Bryan
    Coates, Carrie
    Dorsey, Grant
    Rosenthal, Philip J.
    Charlebois, Edwin
    Lindegardh, Niklas
    Havlir, Diane
    Aweeka, Francesca T.
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (06) : 889 - 891
  • [24] Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals
    Roe, Amy L.
    Krzykwa, Julie
    Calderon, Angela I.
    Bascoul, Cecile
    Gurley, Bill J.
    Koturbash, Igor
    Li, Albert P.
    Liu, Yitong
    Mitchell, Constance A.
    Oketch-Rabah, Hellen
    Si, Lin
    van Breemen, Richard B.
    Walker, Heather
    Ferguson, Stephen S.
    JOURNAL OF DIETARY SUPPLEMENTS, 2025, 22 (01) : 162 - 192
  • [25] The Role of Lysosomes in Limiting Drug Toxicity in Mice
    Ndolo, Rosemary A.
    Forrest, M. Laird
    Krise, Jeffrey P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 120 - 128
  • [26] USE OF SUBMITOCHONDRIAL PARTICLES FOR PREDICTION OF CHEMICAL TOXICITY IN MAN
    KNOBELOCH, LM
    BLONDIN, GA
    HARKIN, JM
    BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 1990, 44 (05) : 661 - 668
  • [27] DRUG-INTERACTION OF ANTITUMOR DRUGS .9. TOXICITY OF DOXORUBICIN IN LIPOPOLYSACCHARIDE-TREATED MICE
    SASAKI, K
    ISHIKAWA, M
    TAKAYANAGI, G
    FOLIA PHARMACOLOGICA JAPONICA, 1985, 85 (06) : P99 - P99
  • [28] Evaluation of a Clinically Relevant Drug-Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity
    Ning, Chen
    Su, Shengdi
    Li, Jiaming
    Kong, Dexuan
    Cai, Hui
    Qin, Zhiying
    Xing, Han
    Chen, Xijing
    He, Jiake
    FRONTIERS IN PHARMACOLOGY, 2021, 12